These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3111704)

  • 21. Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection.
    Ragni MV; Ruben FL; Winkelstein A; Spero JA; Bontempo FA; Lewis JH
    J Lab Clin Med; 1987 May; 109(5):545-9. PubMed ID: 3572201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection through normal heterosexual contact in Uganda.
    Sewankambo NK; Carswell JW; Mugerwa RD; Lloyd G; Kataaha P; Downing RG; Lucas S
    AIDS; 1987 Jul; 1(2):113-6. PubMed ID: 3130076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current state of HIV/AIDS in Taiwan and reappraisal of early diagnostic value of serial and comparative analyses of western blot patterns of HIV infection.
    Chen MY; Chuang CY
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():39-46. PubMed ID: 11890112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers.
    Lake-Bakaar G; Bhat K; Govindarajan S
    J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of evidence for seroconversion to human immunodeficiency virus in recipients of anti-D immunoglobulin containing HIV antibody.
    Babu PG; Cherian T; Jairaj PK; Jayakumari H; John TJ
    Indian J Med Res; 1990 Mar; 91():81-3. PubMed ID: 2160915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B immune globulin and human immunodeficiency virus antibody.
    CMAJ; 1988 Sep; 139(6):520. PubMed ID: 3165686
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety of immune globulin preparations.
    CMAJ; 1988 Sep; 139(6):522. PubMed ID: 3165687
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevalence of anti-HIV antibodies in immunoglobulins recipients].
    Brémard-Oury C; Couroucé AM; Badillet M; Huchet J; Chapelle A; Bierling P; Schuller E; Jullien AM; Habibi B
    Presse Med; 1987 Nov; 16(40):2013-8. PubMed ID: 2962174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus conference evaluates key issues concerning use of intravenous immune globulin.
    Clin Pharm; 1990 Jul; 9(7):489, 492-3. PubMed ID: 2198122
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening cornea donors for antibodies against human immunodeficiency virus. Efficacy of ELISA testing of cadaveric sera and aqueous humor.
    Pepose JS; Pardo F; Kessler JA; Kline R; Donegan E; Quinn TC
    Ophthalmology; 1987 Feb; 94(2):95-100. PubMed ID: 3554092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.
    Prince AM; Horowitz B; Baker L; Shulman RW; Ralph H; Valinsky J; Cundell A; Brotman B; Boehle W; Rey F
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6944-8. PubMed ID: 3413127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody against the human immunodeficiency virus in commercial intravenous gammaglobulin preparations.
    Wood CC; Williams AE; McNamara JG; Annunziata JA; Feorino PM; Conway CO
    Ann Intern Med; 1986 Oct; 105(4):536-8. PubMed ID: 2428274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human immunodeficiency virus (HIV). 1: Transmission and risk of infection].
    Lätzsch I
    Z Arztl Fortbild (Jena); 1988; 82(12):547-51. PubMed ID: 3051709
    [No Abstract]   [Full Text] [Related]  

  • 34. Methods for evaluating the protective activity of intravenous immunoglobulins for neonatal pathogens: entanglement or encouragement?
    Baker CJ; Edwards MS
    Pediatrics; 1990 Dec; 86(6):995-7. PubMed ID: 2123537
    [No Abstract]   [Full Text] [Related]  

  • 35. Childhood immunization, vaccine-preventable diseases and infection with human immunodeficiency virus.
    Onorato IM; Markowitz LE; Oxtoby MJ
    Pediatr Infect Dis J; 1988 Aug; 7(8):588-95. PubMed ID: 3050855
    [No Abstract]   [Full Text] [Related]  

  • 36. Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex?
    Fleming DW; Cochi SL; Steece RS; Hull HF
    JAMA; 1987 Aug; 258(6):785-7. PubMed ID: 3475477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients.
    Schwarz A; Hoffmann F; L'age-Stehr J; Tegzess AM; Offermann G
    Transplantation; 1987 Jul; 44(1):21-4. PubMed ID: 3299918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of seroconversion following treatment with hepatitis B immune globulin containing antibody to human immunodeficiency virus.
    Phillips M; Cummins LM
    Hepatology; 1988; 8(3):497-8. PubMed ID: 3371869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of three ELISAs and Western blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population.
    Nishanian P; Taylor JM; Korns E; Detels R; Saah A; Fahey JL
    J Clin Microbiol; 1987 Feb; 25(2):395-400. PubMed ID: 3546369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous drug abusers and HIV infections: a consequence of their actions.
    Ginzburg HM
    Law Med Health Care; 1986 Dec; 14(5-6):268-72. PubMed ID: 3475518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.